Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.05
-5.86%
Mkt Cap $4.33M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $5.47M | $4.35M | -20.55% | -$0.29 | -$0.35 | -20.69% | — | — |
| Q4 2025 Nov 4, 2025 | $4.26M | $5.60M | +31.55% | -$0.31 | -$0.13 | +58.06% | — | — |
| Q3 2025 Aug 7, 2025 | $4.33M | $4.01M | -7.27% | -$0.51 | -$0.37 | +27.45% | — | — |
| Q2 2025 Jun 17, 2025 | $4.44M | $3.75M | -15.44% | -$0.73 | -$0.15 | +79.45% | — | — |
| Q1 2025 Feb 5, 2025 | $4.44M | $3.56M | -19.73% | -$0.80 | -$0.59 | +26.25% | — | — |
| Q4 2024 Nov 7, 2024 | $4.39M | $3.58M | -18.47% | -$1.00 | -$0.59 | +41.00% | — | — |
| Q3 2024 Aug 8, 2024 | $3.78M | $3.39M | -10.34% | -$0.06 | -$1.40 | -2233.33% | — | — |
| Q2 2024 Jun 17, 2024 | $3.98M | $3.44M | -13.59% | -$3.41 | -$1.40 | +58.92% | — | — |
| Q1 2024 Feb 8, 2024 | $3.98M | $3.14M | -21.16% | -$0.21 | -$1.20 | -471.43% | — | — |
| Q4 2023 Nov 13, 2023 | $3.48M | $2.73M | -21.52% | -$0.24 | -$4.00 | -1566.67% | — | — |
| Q3 2023 Aug 10, 2023 | $3.38M | $3.43M | +1.41% | -$2.40 | -$5.80 | -141.67% | — | — |
| Q2 2023 Jun 21, 2023 | $3.30M | $3.01M | -8.62% | — | -$4.60 | — | — | — |
| Q1 2023 Feb 14, 2023 | — | $2.94M | — | — | -$10.00 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | $3.33M | — | — | -$3.80 | — | — | — |
| Q3 2022 Aug 11, 2022 | — | $3.98M | — | — | -$5.80 | — | — | — |
| Q3 2022 Jul 13, 2022 | — | $2.30M | — | — | -$19.00 | — | — | — |
| Q1 2022 Feb 11, 2022 | — | $2.90M | — | — | -$6.20 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | $3.74M | — | — | -$0.80 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | $3.68M | — | — | -$10.40 | — | — | — |
| Q3 2021 Jul 14, 2021 | — | $2.16M | — | — | -$32.80 | — | — | — |